NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021.

Journal Article (Journal Article)

Over the past few years, the NCCN Guidelines for Melanoma: Cutaneous have been expanded to include pathways for treatment of microscopic satellitosis (added in v2.2020), and the following Principles sections: Molecular Testing (added in v2.2019), Systemic Therapy Considerations (added in v2.2020), and Brain Metastases Management (added in v3.2020). The v1.2021 update included additional modifications of these sections and notable revisions to Principles of: Pathology, Surgical Margins for Wide Excision of Primary Melanoma, Sentinel Lymph Node Biopsy, Completion/Therapeutic Lymph Node Dissection, and Radiation Therapy. These NCCN Guidelines Insights discuss the important changes to pathology and surgery recommendations, as well as additions to systemic therapy options for patients with advanced disease.

Full Text

Duke Authors

Cited Authors

  • Swetter, SM; Thompson, JA; Albertini, MR; Barker, CA; Baumgartner, J; Boland, G; Chmielowski, B; DiMaio, D; Durham, A; Fields, RC; Fleming, MD; Galan, A; Gastman, B; Grossmann, K; Guild, S; Holder, A; Johnson, D; Joseph, RW; Karakousis, G; Kendra, K; Lange, JR; Lanning, R; Margolin, K; Olszanski, AJ; Ott, PA; Ross, MI; Salama, AK; Sharma, R; Skitzki, J; Sosman, J; Wuthrick, E; McMillian, NR; Engh, AM

Published Date

  • April 1, 2021

Published In

Volume / Issue

  • 19 / 4

Start / End Page

  • 364 - 376

PubMed ID

  • 33845460

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2021.0018


  • eng

Conference Location

  • United States